Auto-CD34+ cells
901001
Phase 3 mab completed
Quick answer
Auto-CD34+ cells for Chronic Myocardial Ischemia is a Phase 3 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Chronic Myocardial Ischemia
- Phase
- Phase 3
- Modality
- mab
- Status
- completed